Surgery and Radiation Therapy in Brain Cancer Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1067288
  • December 2021
  • Healthcare
  • 154 Pages
Report Description

This report is a comprehensive study that examines the Surgery and Radiation Therapy in Brain Cancer industry in depth. With reference to key regions and major nations, the study specifies the product type of Surgery and Radiation Therapy in Brain Cancer as well as its use in various industrial verticals. Furthermore, the report identified and analysed all of the top companies functioning in the global Surgery and Radiation Therapy in Brain Cancer market arena, comparing and contrasting them based on market revenue, yearly sales volume, historical growth rate, and company strategies. The worldwide Surgery and Radiation Therapy in Brain Cancer market research offers a business strategy for current market participants to strengthen their market positions based on all of these findings. Furthermore, the paper recommends a market entry strategy for newcomers to the sector.

The top vendors and distributors operating in all of the major regions have also been highlighted in the Surgery and Radiation Therapy in Brain Cancer market report. This data and research should aid market players in strengthening their market distribution networks and expanding their geographic reach.
 
Surgery and Radiation Therapy in Brain Cancer Market Strategic Analysis 

The market was studied using several marketing methodologies such as Porter's Five Forces Analysis, player positioning analysis, SWOT analysis, market share analysis, and value chain analysis in the Surgery and Radiation Therapy in Brain Cancer market study. The market dynamics and factors such as the threat of a Surgery and Radiation Therapy in Brain Cancer substitute, the threat of new entrants into the Surgery and Radiation Therapy in Brain Cancer market, buyer bargaining power, supplier bargaining power to Surgery and Radiation Therapy in Brain Cancer providing companies, and internal rivalry among Surgery and Radiation Therapy in Brain Cancer providers are analysed in Porter's Five Forces analysis to provide the report's readers with a detailed view of the current market dynamics.

This analysis assists report users in evaluating the Surgery and Radiation Therapy in Brain Cancer market based on various parameters such as economies of scale, switching costs, brand loyalty, existing distribution channels, capital investments, manufacturing rights & patents, government regulations, advertising impact, and consumer preference impact. This simplified data is expected to aid the industry's key decision-makers in their decision-making process. Furthermore, this study answers the crucial question of whether or not new entrants should enter the Surgery and Radiation Therapy in Brain Cancer industry.
 
Surgery and Radiation Therapy in Brain Cancer Market Key Trends Analysis

The important factors influencing the growth of the Surgery and Radiation Therapy in Brain Cancer market have been examined in this report. The driving factors that are boosting demand for Surgery and Radiation Therapy in Brain Cancers and the restraining factors that are slowing growth of the Surgery and Radiation Therapy in Brain Cancer industry are addressed in depth, as well as their implications for the worldwide Surgery and Radiation Therapy in Brain Cancer market. In addition, the published analysis identifies and discusses in detail the trends that are driving the market and impacting its growth. In addition, other qualitative variables such as risks connected with operations and key problems faced by market players are covered in the report.

Surgery and Radiation Therapy in Brain Cancer Market Key Segment Analysis

By segmenting the market by product type, application, and geography, the study provides a clear picture of the Surgery and Radiation Therapy in Brain Cancer industry. On the basis of current and future trends, all segments of the Surgery and Radiation Therapy in Brain Cancer industry have been examined. The market and its divisions are forecasted for the years 2021 through 2028. The study identifies the categories that are contributing the most to total market revenue growth, as well as the factors that are supporting their growth.

The research will provide a detailed qualitative and quantitative product type segment analysis for the years 2021 to 2028.

The report study analyses and includes a variety of prospective prospects and aspects affecting various applications.
 
Surgery and Radiation Therapy in Brain Cancer Market Regional Trends and Market Player’s Analysis

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa are the regions in which the market is divided. In 2020, the worldwide Surgery and Radiation Therapy in Brain Cancer market was dominated by North America. The Asia Pacific region is expected to have the highest CAGR for the Surgery and Radiation Therapy in Brain Cancer market throughout the projected period.


 
The market revenue, market shares, business strategies, recent developments, and growth rates of major players with substantial market shares in the global Surgery and Radiation Therapy in Brain Cancer market are all examined. These firms' recent developments, such as new solution/product launches, research projects, acquisitions, geographic expansions, and technological advancements, are taken into account when determining their position in the Surgery and Radiation Therapy in Brain Cancer market. All important stakeholders in the Surgery and Radiation Therapy in Brain Cancer value chain and technological ecosystem are expected to benefit from the insights offered in the Surgery and Radiation Therapy in Brain Cancer market research study.

In order to provide a broader understanding of the top competitors in the Surgery and Radiation Therapy in Brain Cancer market, the research includes a company market share analysis. Accuray Incorporated, Ion Beam Applications SA, Eckert & Ziegler, Hitachi Ltd., Varian Medical Systems Inc., GT Medical Technologies Inc., Elekta AB (publ), Xoft Inc., IntraOp Medical Inc, Isoray Inc., Mevion, ViewRay, ZEISS, Sensus Healthcare, Theragenics, Optivus Proton Therapy, S.I.T. Sordina IORT Technologies S.p.A., Integra LifeSciences Corporation, Misonix Inc, Söring GmbH, Stryker Corporation, Olympus Corporation, KARL STORZ SE & Co. KG, B. Braun Melsungen AG, adeor medical AG, Machida Endoscopes, Clarus Medical, Medtronic plc, Penumbra Inc. are among the major participants in the global Surgery and Radiation Therapy in Brain Cancer industry.
 
Scope of the report
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2021
Forecast Period Covered 2021-2028
Units for value Revenue in USD million and CAGR from 2021 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Accuray Incorporated, Ion Beam Applications SA, Eckert & Ziegler, Hitachi Ltd., Varian Medical Systems Inc., GT Medical Technologies Inc., Elekta AB (publ), Xoft Inc., IntraOp Medical Inc, Isoray Inc., Mevion, ViewRay, ZEISS, Sensus Healthcare, Theragenics, Optivus Proton Therapy, S.I.T. Sordina IORT Technologies S.p.A., Integra LifeSciences Corporation, Misonix Inc, Söring GmbH, Stryker Corporation, Olympus Corporation, KARL STORZ SE & Co. KG, B. Braun Melsungen AG, adeor medical AG, Machida Endoscopes, Clarus Medical, Medtronic plc, Penumbra Inc.
 
Major Highlights of the Surgery and Radiation Therapy in Brain Cancer Market report study:
  • An in-depth examination of the global Surgery and Radiation Therapy in Brain Cancer industry will be published soon.
  • The study examines the global Surgery and Radiation Therapy in Brain Cancer market and offers major actionable information to its players.
  • The research has taken into account all key events in the recent past, providing users with up-to-date industry information.
  • The report study is expected to aid the industry's key decision-makers in their decision-making process.
  • Data on market intelligence, changing market dynamics, existing and predicted market trends, and so on are included in the report.
  • The research includes a detailed examination of the macroeconomic and microeconomic aspects that influence the global Surgery and Radiation Therapy in Brain Cancer industry.
  • The Market Ecosystem and Adoption in Different Markets
  • The global Surgery and Radiation Therapy in Brain Cancer market is being shaped by several major trends.
  • The size of the Surgery and Radiation Therapy in Brain Cancer market in terms of revenue has been measured in the past and will be measured in the future in USD million.
  • Consumer preference patterns and recent industrial developments
  • The worldwide Surgery and Radiation Therapy in Brain Cancer market's competitive landscape and player positioning analysis
  • Major players' key goods and solutions, as well as their business strategies
  • Recommendations for new market entrants as well as existing market participants.
  • The study of niche and potential segments (product type, application, and regions/countries) predicts that promising growth will be noticed.
  • Operating players in the market encounter a number of significant hurdles.
  • An examination of the major risks involved in market operations
 
The report segment of the global Surgery and Radiation Therapy in Brain Cancer market as follows:
Global Surgery and Radiation Therapy in Brain Cancer Market: By Product Type

  • Type I
  • Type II
  • Type III

Global Surgery and Radiation Therapy in Brain Cancer Market: By Application
  • Application I
  • Application II
  • Application III

Global Surgery and Radiation Therapy in Brain Cancer Market: By Region
  • North America
    • U.S.
    • Canada
    • Rest of North America
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China 
    • Japan
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

The report study is drafted to provide actionable insights to the following mentioned audience:
  • Institutes of research and consulting firms
  • Companies are attempting to get into the Surgery and Radiation Therapy in Brain Cancer market.
  • Universities and students
  • Other companies in the Surgery and Radiation Therapy in Brain Cancer market include solution providers, product producers, service providers, and others.
  • Private companies and government agencies that are linked
  • Individuals interested in learning more about the Surgery and Radiation Therapy in Brain Cancer market

Manufacturers and Segments

  • Accuray Incorporated
  • Ion Beam Applications SA
  • Eckert & Ziegler
  • Hitachi Ltd.
  • Varian Medical Systems Inc.
  • GT Medical Technologies Inc.
  • Elekta AB (publ)
  • Xoft Inc.
  • IntraOp Medical Inc
  • Isoray Inc.
  • Mevion
  • ViewRay
  • ZEISS
  • Sensus Healthcare
  • Theragenics
  • Optivus Proton Therapy
  • S.I.T. Sordina IORT Technologies S.p.A.
  • Integra LifeSciences Corporation
  • Misonix Inc
  • Söring GmbH
  • Stryker Corporation
  • Olympus Corporation
  • KARL STORZ SE & Co. KG
  • B. Braun Melsungen AG
  • adeor medical AG
  • Machida Endoscopes
  • Clarus Medical
  • Medtronic plc
  • Penumbra Inc.
  • Type I
  • Type II
  • Type III
  • Application I
  • Application II
  • Application III

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Surgery and Radiation Therapy in Brain Cancer Market Snapshot
          2.1.1. Global Surgery and Radiation Therapy in Brain Cancer Market By Type I,2019
               2.1.1.1.
               2.1.1.2.Type I I
               2.1.1.3.Type I II
          2.1.2. Global Surgery and Radiation Therapy in Brain Cancer Market By Application I,2019
               2.1.2.1.
               2.1.2.2.Application I I
               2.1.2.3.Application I II
          2.1.3. Global Surgery and Radiation Therapy in Brain Cancer Market By End-use,2019
          2.1.4. Global Surgery and Radiation Therapy in Brain Cancer Market By Geography,2019

3. Global Surgery and Radiation Therapy in Brain Cancer Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Surgery and Radiation Therapy in Brain Cancer Market Size (US$), By Type I, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type I, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type I, 2020
     4.2. Global Surgery and Radiation Therapy in Brain Cancer Market Size (US$), By Type I, 2018 – 2028

5. Global Surgery and Radiation Therapy in Brain Cancer Market Size (US$), By Application I, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application I, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application I, 2020
     5.2. Global Surgery and Radiation Therapy in Brain Cancer Market Size (US$), By Application I, 2018 – 2028

6. Global Surgery and Radiation Therapy in Brain Cancer Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Surgery and Radiation Therapy in Brain Cancer Market Size (US$), By End-use, 2018 – 2028

7. Global Surgery and Radiation Therapy in Brain Cancer Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Surgery and Radiation Therapy in Brain Cancer Market Analysis, 2018 – 2028 
          7.2.1. North America Surgery and Radiation Therapy in Brain Cancer Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Surgery and Radiation Therapy in Brain Cancer Market Size (US$), By Type I, 2018 – 2028
          7.2.3. North America Surgery and Radiation Therapy in Brain Cancer Market Size (US$), By Application I, 2018 – 2028
          7.2.4. North America Surgery and Radiation Therapy in Brain Cancer Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Surgery and Radiation Therapy in Brain Cancer Market Analysis, 2018 – 2028 
          7.3.1.  Europe Surgery and Radiation Therapy in Brain Cancer Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Surgery and Radiation Therapy in Brain Cancer Market Size (US$), By Type I, 2018 – 2028
          7.3.3. Europe Surgery and Radiation Therapy in Brain Cancer Market Size (US$), By Application I, 2018 – 2028
          7.3.4. Europe Surgery and Radiation Therapy in Brain Cancer Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Surgery and Radiation Therapy in Brain Cancer Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Surgery and Radiation Therapy in Brain Cancer Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Surgery and Radiation Therapy in Brain Cancer Market Size (US$), By Type I, 2018 – 2028
          7.4.3. Asia Pacific Surgery and Radiation Therapy in Brain Cancer Market Size (US$), By Application I, 2018 – 2028
          7.4.4. Asia Pacific Surgery and Radiation Therapy in Brain Cancer Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Surgery and Radiation Therapy in Brain Cancer Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Surgery and Radiation Therapy in Brain Cancer Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Surgery and Radiation Therapy in Brain Cancer Market Size (US$), By Type I, 2018 – 2028
          7.5.3. Latin America Surgery and Radiation Therapy in Brain Cancer Market Size (US$), By Application I, 2018 – 2028
          7.5.4. Latin America Surgery and Radiation Therapy in Brain Cancer Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Surgery and Radiation Therapy in Brain Cancer Market Analysis, 2018 – 2028 
          7.6.1.  MEA Surgery and Radiation Therapy in Brain Cancer Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Surgery and Radiation Therapy in Brain Cancer Market Size (US$), By Type I, 2018 – 2028
          7.6.3. MEA Surgery and Radiation Therapy in Brain Cancer Market Size (US$), By Application I, 2018 – 2028
          7.6.4. MEA Surgery and Radiation Therapy in Brain Cancer Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Surgery and Radiation Therapy in Brain Cancer Providers
        8.4.1 Accuray Incorporated
                8.4.1.1 Business Description
                8.4.1.2 Accuray Incorporated Geographic Operations
                8.4.1.3 Accuray Incorporated Financial Information
                8.4.1.4 Accuray Incorporated Product Positions/Portfolio
                8.4.1.5 Accuray Incorporated Key Developments
        8.4.2 Ion Beam Application Is SA
                8.4.2.1 Business Description
                8.4.2.2 Ion Beam Application Is SA Geographic Operations
                8.4.2.3 Ion Beam Application Is SA Financial Information
                8.4.2.4 Ion Beam Application Is SA Product Positions/Portfolio
                8.4.2.5 Ion Beam Application Is SA Key Developments
        8.4.3 Eckert & Ziegler
                8.4.3.1 Business Description
                8.4.3.2 Eckert & Ziegler Geographic Operations
                8.4.3.3 Eckert & Ziegler Financial Information
                8.4.3.4 Eckert & Ziegler Product Positions/Portfolio
                8.4.3.5 Eckert & Ziegler Key Developments
        8.4.4 Hitachi Ltd.
                8.4.4.1 Business Description
                8.4.4.2 Hitachi Ltd. Geographic Operations
                8.4.4.3 Hitachi Ltd. Financial Information
                8.4.4.4 Hitachi Ltd. Product Positions/Portfolio
                8.4.4.5 Hitachi Ltd. Key Developments
        8.4.5 Varian Medical Systems Inc.
                8.4.5.1 Business Description
                8.4.5.2 Varian Medical Systems Inc. Geographic Operations
                8.4.5.3 Varian Medical Systems Inc. Financial Information
                8.4.5.4 Varian Medical Systems Inc. Product Positions/Portfolio
                8.4.5.5 Varian Medical Systems Inc. Key Developments
        8.4.6 GT Medical Technologies Inc.
                8.4.6.1 Business Description
                8.4.6.2 GT Medical Technologies Inc. Geographic Operations
                8.4.6.3 GT Medical Technologies Inc. Financial Information
                8.4.6.4 GT Medical Technologies Inc. Product Positions/Portfolio
                8.4.6.5 GT Medical Technologies Inc. Key Developments
        8.4.7 Elekta AB (publ)
                8.4.7.1 Business Description
                8.4.7.2 Elekta AB (publ) Geographic Operations
                8.4.7.3 Elekta AB (publ) Financial Information
                8.4.7.4 Elekta AB (publ) Product Positions/Portfolio
                8.4.7.5 Elekta AB (publ) Key Developments
        8.4.8 Xoft Inc.
                8.4.8.1 Business Description
                8.4.8.2 Xoft Inc. Geographic Operations
                8.4.8.3 Xoft Inc. Financial Information
                8.4.8.4 Xoft Inc. Product Positions/Portfolio
                8.4.8.5 Xoft Inc. Key Developments
        8.4.9 IntraOp Medical Inc
                8.4.9.1 Business Description
                8.4.9.2 IntraOp Medical Inc Geographic Operations
                8.4.9.3 IntraOp Medical Inc Financial Information
                8.4.9.4 IntraOp Medical Inc Product Positions/Portfolio
                8.4.9.5 IntraOp Medical Inc Key Developments
        8.4.10 Isoray Inc.
                8.4.10.1 Business Description
                8.4.10.2 Isoray Inc. Geographic Operations
                8.4.10.3 Isoray Inc. Financial Information
                8.4.10.4 Isoray Inc. Product Positions/Portfolio
                8.4.10.5 Isoray Inc. Key Developments
        8.4.11 Mevion
                8.4.11.1 Business Description
                8.4.11.2 Mevion Geographic Operations
                8.4.11.3 Mevion Financial Information
                8.4.11.4 Mevion Product Positions/Portfolio
                8.4.11.5 Mevion Key Developments
        8.4.12 ViewRay
                8.4.12.1 Business Description
                8.4.12.2 ViewRay Geographic Operations
                8.4.12.3 ViewRay Financial Information
                8.4.12.4 ViewRay Product Positions/Portfolio
                8.4.12.5 ViewRay Key Developments
        8.4.13 ZEISS
                8.4.13.1 Business Description
                8.4.13.2 ZEISS Geographic Operations
                8.4.13.3 ZEISS Financial Information
                8.4.13.4 ZEISS Product Positions/Portfolio
                8.4.13.5 ZEISS Key Developments
        8.4.14 Sensus Healthcare
                8.4.14.1 Business Description
                8.4.14.2 Sensus Healthcare Geographic Operations
                8.4.14.3 Sensus Healthcare Financial Information
                8.4.14.4 Sensus Healthcare Product Positions/Portfolio
                8.4.14.5 Sensus Healthcare Key Developments
        8.4.15 Theragenics
                8.4.15.1 Business Description
                8.4.15.2 Theragenics Geographic Operations
                8.4.15.3 Theragenics Financial Information
                8.4.15.4 Theragenics Product Positions/Portfolio
                8.4.15.5 Theragenics Key Developments
        8.4.16 Optivus Proton Therapy
                8.4.16.1 Business Description
                8.4.16.2 Optivus Proton Therapy Geographic Operations
                8.4.16.3 Optivus Proton Therapy Financial Information
                8.4.16.4 Optivus Proton Therapy Product Positions/Portfolio
                8.4.16.5 Optivus Proton Therapy Key Developments
        8.4.17 S.I.T. Sordina IORT Technologies S.p.A.
                8.4.17.1 Business Description
                8.4.17.2 S.I.T. Sordina IORT Technologies S.p.A. Geographic Operations
                8.4.17.3 S.I.T. Sordina IORT Technologies S.p.A. Financial Information
                8.4.17.4 S.I.T. Sordina IORT Technologies S.p.A. Product Positions/Portfolio
                8.4.17.5 S.I.T. Sordina IORT Technologies S.p.A. Key Developments
        8.4.18 Integra LifeSciences Corporation
                8.4.18.1 Business Description
                8.4.18.2 Integra LifeSciences Corporation Geographic Operations
                8.4.18.3 Integra LifeSciences Corporation Financial Information
                8.4.18.4 Integra LifeSciences Corporation Product Positions/Portfolio
                8.4.18.5 Integra LifeSciences Corporation Key Developments
        8.4.19 Misonix Inc
                8.4.19.1 Business Description
                8.4.19.2 Misonix Inc Geographic Operations
                8.4.19.3 Misonix Inc Financial Information
                8.4.19.4 Misonix Inc Product Positions/Portfolio
                8.4.19.5 Misonix Inc Key Developments
        8.4.20 Söring GmbH
                8.4.20.1 Business Description
                8.4.20.2 Söring GmbH Geographic Operations
                8.4.20.3 Söring GmbH Financial Information
                8.4.20.4 Söring GmbH Product Positions/Portfolio
                8.4.20.5 Söring GmbH Key Developments
        8.4.21 Stryker Corporation
                8.4.21.1 Business Description
                8.4.21.2 Stryker Corporation Geographic Operations
                8.4.21.3 Stryker Corporation Financial Information
                8.4.21.4 Stryker Corporation Product Positions/Portfolio
                8.4.21.5 Stryker Corporation Key Developments
        8.4.22 Olympus Corporation
                8.4.22.1 Business Description
                8.4.22.2 Olympus Corporation Geographic Operations
                8.4.22.3 Olympus Corporation Financial Information
                8.4.22.4 Olympus Corporation Product Positions/Portfolio
                8.4.22.5 Olympus Corporation Key Developments
        8.4.23 KARL STORZ SE & Co. KG
                8.4.23.1 Business Description
                8.4.23.2 KARL STORZ SE & Co. KG Geographic Operations
                8.4.23.3 KARL STORZ SE & Co. KG Financial Information
                8.4.23.4 KARL STORZ SE & Co. KG Product Positions/Portfolio
                8.4.23.5 KARL STORZ SE & Co. KG Key Developments
        8.4.24 B. Braun Melsungen AG
                8.4.24.1 Business Description
                8.4.24.2 B. Braun Melsungen AG Geographic Operations
                8.4.24.3 B. Braun Melsungen AG Financial Information
                8.4.24.4 B. Braun Melsungen AG Product Positions/Portfolio
                8.4.24.5 B. Braun Melsungen AG Key Developments
        8.4.25 adeor medical AG
                8.4.25.1 Business Description
                8.4.25.2 adeor medical AG Geographic Operations
                8.4.25.3 adeor medical AG Financial Information
                8.4.25.4 adeor medical AG Product Positions/Portfolio
                8.4.25.5 adeor medical AG Key Developments
        8.4.26 Machida Endoscopes
                8.4.26.1 Business Description
                8.4.26.2 Machida Endoscopes Geographic Operations
                8.4.26.3 Machida Endoscopes Financial Information
                8.4.26.4 Machida Endoscopes Product Positions/Portfolio
                8.4.26.5 Machida Endoscopes Key Developments
        8.4.27 Clarus Medical
                8.4.27.1 Business Description
                8.4.27.2 Clarus Medical Geographic Operations
                8.4.27.3 Clarus Medical Financial Information
                8.4.27.4 Clarus Medical Product Positions/Portfolio
                8.4.27.5 Clarus Medical Key Developments
        8.4.28 Medtronic plc
                8.4.28.1 Business Description
                8.4.28.2 Medtronic plc Geographic Operations
                8.4.28.3 Medtronic plc Financial Information
                8.4.28.4 Medtronic plc Product Positions/Portfolio
                8.4.28.5 Medtronic plc Key Developments
        8.4.29 Penumbra Inc.
                8.4.29.1 Business Description
                8.4.29.2 Penumbra Inc. Geographic Operations
                8.4.29.3 Penumbra Inc. Financial Information
                8.4.29.4 Penumbra Inc. Product Positions/Portfolio
                8.4.29.5 Penumbra Inc. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Surgery and Radiation Therapy in Brain Cancer Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Surgery and Radiation Therapy in Brain Cancer Market Revenue, By Type I, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Surgery and Radiation Therapy in Brain Cancer Market Revenue, By Application I, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Surgery and Radiation Therapy in Brain Cancer Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Surgery and Radiation Therapy in Brain Cancer Market Revenue, By Type I, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Surgery and Radiation Therapy in Brain Cancer Market Revenue, By Application I, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Surgery and Radiation Therapy in Brain Cancer Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Surgery and Radiation Therapy in Brain Cancer Market Revenue, By Type I, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Surgery and Radiation Therapy in Brain Cancer Market Revenue, By Application I, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Surgery and Radiation Therapy in Brain Cancer Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Surgery and Radiation Therapy in Brain Cancer Market Revenue, By Type I, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Surgery and Radiation Therapy in Brain Cancer Market Revenue, By Application I, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Surgery and Radiation Therapy in Brain Cancer Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Surgery and Radiation Therapy in Brain Cancer Market Revenue, By Type I, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Surgery and Radiation Therapy in Brain Cancer Market Revenue, By Application I, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Surgery and Radiation Therapy in Brain Cancer Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Surgery and Radiation Therapy in Brain Cancer: Market Segmentation 
FIG. 2 Global Surgery and Radiation Therapy in Brain Cancer Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Surgery and Radiation Therapy in Brain Cancer Market, By Type I, 2019 (US$ Mn) 
FIG. 5 Global Surgery and Radiation Therapy in Brain Cancer Market, By Application I, 2019 (US$ Mn) 
FIG. 6 Global Surgery and Radiation Therapy in Brain Cancer Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Surgery and Radiation Therapy in Brain Cancer Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Surgery and Radiation Therapy in Brain Cancer Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Surgery and Radiation Therapy in Brain Cancer Providers, 2019
FIG. 11 Global Surgery and Radiation Therapy in Brain Cancer Market Revenue Contribution, By Type I, 2019 & 2028 (Value %) 
FIG. 12 Global Surgery and Radiation Therapy in Brain Cancer Market Revenue Contribution, By Application I, 2019 & 2028 (Value %) 
FIG. 13 Global Surgery and Radiation Therapy in Brain Cancer Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Surgery and Radiation Therapy in Brain Cancer Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Surgery and Radiation Therapy in Brain Cancer Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Surgery and Radiation Therapy in Brain Cancer Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Surgery and Radiation Therapy in Brain Cancer Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Surgery and Radiation Therapy in Brain Cancer Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Surgery and Radiation Therapy in Brain Cancer market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Surgery and Radiation Therapy in Brain Cancer Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Surgery and Radiation Therapy in Brain Cancer Market Value, By Segment1, 2018 – 2028
TABLE  North America Surgery and Radiation Therapy in Brain Cancer Market Value, By Segment2, 2018 – 2028
TABLE  North America Surgery and Radiation Therapy in Brain Cancer Market Value, By Country, 2018 – 2028
TABLE  Europe Surgery and Radiation Therapy in Brain Cancer Market Value, By Segment1, 2018 – 2028
TABLE  Europe Surgery and Radiation Therapy in Brain Cancer Market Value, By Segment2, 2018 – 2028
TABLE  Europe Surgery and Radiation Therapy in Brain Cancer Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Surgery and Radiation Therapy in Brain Cancer Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Surgery and Radiation Therapy in Brain Cancer Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Surgery and Radiation Therapy in Brain Cancer Market Value, By Country, 2018 – 2028
TABLE  Latin America Surgery and Radiation Therapy in Brain Cancer Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Surgery and Radiation Therapy in Brain Cancer Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Surgery and Radiation Therapy in Brain Cancer Market Value, By Country, 2018 – 2028
TABLE  MEA Surgery and Radiation Therapy in Brain Cancer Market Value, By Segment1, 2018 – 2028
TABLE  MEA Surgery and Radiation Therapy in Brain Cancer Market Value, By Segment2, 2018 – 2028
TABLE  MEA Surgery and Radiation Therapy in Brain Cancer Market Value, By Country, 2018 – 2028
TABLE  Accuray Incorporated: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Ion Beam Applications SA: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Eckert & Ziegler: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Hitachi Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Varian Medical Systems Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GT Medical Technologies Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Elekta AB (publ): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Xoft Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  IntraOp Medical Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Isoray Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Mevion: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ViewRay: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ZEISS: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sensus Healthcare: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Theragenics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Optivus Proton Therapy: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  S.I.T. Sordina IORT Technologies S.p.A.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Integra LifeSciences Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Misonix Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Söring GmbH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Stryker Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Olympus Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  KARL STORZ SE & Co. KG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  B. Braun Melsungen AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  adeor medical AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Machida Endoscopes: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Clarus Medical: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Medtronic plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Penumbra Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Surgery and Radiation Therapy in Brain Cancer Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Surgery and Radiation Therapy in Brain Cancer Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Surgery and Radiation Therapy in Brain Cancer Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Surgery and Radiation Therapy in Brain Cancer Market, By Geography, 2019 (US$ Mn)
FIG.  Global Surgery and Radiation Therapy in Brain Cancer Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Surgery and Radiation Therapy in Brain Cancer Providers, 2016
FIG.  Global Surgery and Radiation Therapy in Brain Cancer Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Type I Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Type II Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Type III Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Surgery and Radiation Therapy in Brain Cancer Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Application I Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Application II Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Application III Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Surgery and Radiation Therapy in Brain Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Surgery and Radiation Therapy in Brain Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Surgery and Radiation Therapy in Brain Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Surgery and Radiation Therapy in Brain Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Surgery and Radiation Therapy in Brain Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Surgery and Radiation Therapy in Brain Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Surgery and Radiation Therapy in Brain Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Surgery and Radiation Therapy in Brain Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Surgery and Radiation Therapy in Brain Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Surgery and Radiation Therapy in Brain Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Surgery and Radiation Therapy in Brain Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Surgery and Radiation Therapy in Brain Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Surgery and Radiation Therapy in Brain Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Surgery and Radiation Therapy in Brain Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Surgery and Radiation Therapy in Brain Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Surgery and Radiation Therapy in Brain Cancer Market Value, 2018 – 2028, (US$ Mn)